New Orleans 2026

INNOVATORS POP-UP | MOMENTS OF WONDER
October 8, 2026

Mardi Gras World
1380 Port of New Orleans Place
New Orleans, LA 70130

Register Now

Every Great Innovation Begins with a Moment of Wonder.

A question.

An unexpected conversation.

A technology you’ve never seen before.

A connection that changes everything.

Innovators Pop-Up is built around these moments – the ones that spark curiosity, challenge assumptions, and inspire what’s next in ophthalmology.

Join physicians, founders, investors, strategic partners, and industry leaders for an immersive evening where innovation isn’t simply displayed—it comes to life.

This is not your average reception.

It’s where wonder leads to what’s next.

Showcase Innovators

SPONSORS

Valitor Inc

www.valitorbio.com

Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients. The company is initially focused on developing long-acting molecules aimed at capturing several large markets in ophthalmology. Valitor’s lead product is a long-acting inhibitor of VEGF designed to reliably extend the duration of a single dose in humans to six months or more, which would offer a substantial benefit for the majority of patients that require dosing approximately every 8-12 weeks with the current market leaders. Valitor’s proprietary platform technology has been shown in preclinical models to safely enable intravitreal treatment with unprecedented target tissue durability and potency. For more information on the company, please visit its website at https://www.valitorbio.com/.

Amaros

https://amaros.ai/

Amaros’ EvidenceEngine™ is an AI-powered platform designed to unify and transform fragmented ophthalmic data into actionable intelligence, revolutionizing clinical development, research, and therapeutic decision-making across the eye care continuum. Built in Silicon Valley and backed by serial ophthalmic entrepreneurs, AI scientists, clinicians, and CRO experts, the platform targets a critical bottleneck in ophthalmology: disconnected datasets that hinder efficient trials, slow adoption of therapies, and limit patient access.